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Lesions
Andrada Seicean, Voicu Rednic and Radu Seicean
Abstract
Subepithelial tumors (SETs) in the upper digestive tract are rare and only 10% 
of are located in the duodenum. Assessment of lesions protruding from the duode-
nal wall is difficult. Upper gastrointestinal (GI) endoscopy and computed tomogra-
phy (CT) are not able to completely distinguish between different tumors and guide 
their subsequent management. Endoscopic ultrasonography (EUS) has a significant 
diagnostic yield in this context. EUS is able to accurately diagnose duodenal lesions, 
perform a biopsy if considered useful, guide the approach for resection and pro-
vide appropriate follow-up. SETs reported during upper GI endoscopy are more 
commonly cysts, polyps, lipomas, Brunner’s gland adenoma, ectopic pancreas, 
gastrointestinal stromal tumors (GISTs) or neuroendocrine tumors (NETs). In 
addition, although more rarely, adenocarcinomas and lymphomas can be identified. 
EUS should be performed for any duodenal lesion larger than 1 cm that lacks the 
endoscopic characteristics of a cyst or a lipoma.
Keywords: subepithelial tumors, intramural lesions, endoscopic ultrasound, 
duodenum, endoscopy, interventional endoscopy
1. Introduction
Lesions of the upper gastrointestinal (GI) tract are usually assessed by esopha-
gogastroduodenoscopy (EGD), but less importance is shown for lesions of the small 
intestine. Protrusive lesions of the small intestine can arise from mucosa, with 
endoscopic features that allow their characterization. However, deep organ involve-
ment cannot be assessed by endoscopy. The same is true for lesions from subepithe-
lial layers, known as subepithelial lesions (SELs). These appear as bulging lesions 
covered by normal mucosa, and are firm as they are “palpated” with closed biopsy 
forceps. The mucosa covering these lesions is usually normal, and standard biopsies 
or “bite-to-bite” biopsies have low diagnostic accuracy. Assessing these lesions can 
be difficult, as computed tomography (CT) and magnetic resonance imaging (MRI) 
lack the resolution to properly describe them because of their size.
Endoscopic ultrasound (EUS) overcomes these drawbacks. Due to high resolu-
tion and ability to differentiate between all layers of the GI tract [1], EUS assesses 
the layer of origin, size, morphologic features, and involvement of the neighboring 
organs. Combined with the possibility of targeted biopsies from the deeper layers, 
EUS is the most effective for evaluating SETs of the duodenum.
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SETs of the duodenum can be true intramural lesions of the duodenal wall or 
extrinsic compressions. Extrinsic compression comes from adjacent structures, like 
the gallbladder or blood vessels. Around 1 in 5 SETs found in the upper GI tract is 
an extramural compression [2, 3]. Data regarding external compressions on the 
duodenum are few, but clinical experience suggests that they are less frequent than 
in the stomach. Intramural lesions can be true submucosal or pseudo-submucosal 
lesions. The latter are usually polyps or inflammatory lesions. True submucosal 
lesions originate from one of the deeper layers of the duodenal wall. Benign SETs 
of the duodenum include cysts, gastrointestinal stromal tumors (GISTs), leiomyo-
mas (very rare) of the minor papilla (which at EGD can be confused with SETs), 
lipomas, neuroendocrine tumors (NETs) and ectopic pancreas. Malignant SETs can 
be malignant mesenchymal tumors, adenocarcinomas or lymphomas (Table 1).
A correct and complete diagnosis of an SET, including extension and proximity 
to other structures, is essential in deciding the following steps, as the complex local-
ization and surroundings of the duodenum make surgical interventions difficult. Its 
thin walls and proximity to the biliary and pancreatic ducts makes even endoscopic 
therapeutic interventions more prone to serious complications like perforation. 
In this context, the diagnosis, prognosis and possible therapeutic options should 
always be properly weighed and presented to the patient before a decision is made.
SETs should be resected, endoscopically or surgically, if there is a suspicion 
of malignancy or if they are symptomatic. Tumors with malignant potential, like 
GISTs or NETs, should be resected, or in certain circumstances followed endoscopi-
cally. EUS can help guide the treatment. Generally, lesions limited to the mucosa 
and submucosa can be removed endoscopically, with a high safety profile, using 
advanced techniques like endoscopic submucosal resection (ESD). Tumors arising 
from the muscularis usually need surgical intervention.
Xu et al. [4] Markovic et al. [5] Kawamoto et al. [6]
Total number 169 80 24
Mucosal lesions
Inflammatory protruding or polyps 36 (21%) 13 (16%) 1(4%)
Submucosal lesions
Cysts 40 (24%) — 8(34%)
Brunner’s adenoma 25(15%) 7 (9%) 6(25%)
Lymphangioma — — 1(4%)
Lipoma 6 (4%) 6 (8%) 1(4%)
Ectopic pancreas 19(11%) — 1(4%)
Stromal tumors 17 (10%) 33 (41%) 1(4%)
NET — 3 (4%) —
Gangliocytic paraganglionas — — 1(4%)
Others
Extrinsic compression 12(7%) — —
Minor papilla 12(7%) — —
Malignant tumors
Malignant tumors 2 (1%) 18 (22%) 4(17%)
Table 1. 
Different studies evaluating the final diagnosis in duodenal lesions referred to EUS. Most, but not all, are 
confirmed histologically after EUS.
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2. Evaluation of a duodenal subepithelial tumor
2.1 Initial evaluation
SETs identified in the upper GI tract are rare, being found in around 1 in 300 
EGDs [7]. Only around 10% of those are located in the duodenum [8]. The true 
prevalence probably remains unknown, as most SETs are asymptomatic and are 
found to be completely unrelated to the reason the EGD was performed. In a 
study involving 346 EUS examinations of upper GI SETs, 87% of the lesions were 
unrelated to the presenting symptoms of the patient [2]. The rare symptomatic 
cases usually manifest through occult bleeding or abdominal pain. Evaluation of 
a duodenal SET starts during the initial EGD. Its location, size, mobility and color 
should be noted. Modifications of the mucosa and “tenting” sign are also important. 
A firm lesion with a “pillow” sign is usually a lipoma, while a firm and translucent 
lesion can be a cyst. A central depression along mucosal irregularities can suggest 
an ectopic pancreas, while a central ulceration can be a sign of a GIST. Mucosal 
biopsies are rarely useful, as they only touch the mucosa and are unable to retrieve 
tissue from the lesion. More invasive methods, like “buttonhole” biopsies or jumbo 
forceps, are not always successful and carry high risk of adverse events [9]. If the 
lesion is not a cyst or lipoma, tissue acquisition should be performed for diagnosis, 
especially because some of the duodenal SELs have malignant potential.
2.2 Endoscopic ultrasound
The endosonographic morphology of SETs is based on size, layer of origin, 
echogenicity, echotexture, vascularity and lymph nodes [2]. The procedure is 
difficult in cases of large lesions or inaccessible regions like the jejunum, ileum or, 
sometimes, the fourth part of the duodenum.
Size should be reported in two orthogonal planes. There are five layers visible 
when examining the digestive tract. The first layer (hyperechoic) is the interface of 
the superficial mucosa with the contrast medium. The second layer (hypoechoic) 
is the deep part of the mucosa, containing the muscularis mucosae and lamina 
propria. The third layer (hyperechoic) is the submucosa and the interface between 
the submucosa and the muscularis propria. The fourth layer (hypoechoic) is the 
muscularis propria. The fifth layer is the serosa and the interface with adjacent 
structures. In addition, an SET described at EGD, as mentioned before, can actu-
ally be an extrinsic compression, originating beyond all layers. The relation with 
adjacent layers and structures has to be described. Are the layers immediately above 
and below distinguishable? Do they present ulcerations or irregularities? Can the 
neighboring structures be clearly distinguished or is there invasion? All these ques-
tions should be answered in a correctly redacted EUS result. The echogenicity of 
the tumor has to be noted. It can be anechoic (compare to the water in the lumen), 
hypoechoic (compare to muscularis propria), hyperechoic (compare to submucosa). 
The texture can also give useful information, as inhomogeneous lesions can raise 
suspicions of malignancy, as can irregular margins. For further description one 
can also mention the adjacent vascularization, presence of regional lymph nodes, 
hepatic lesions or free liquid in the peritoneum. Of all the characteristics men-
tioned, the most important are layer of origin and echogenicity (Table 2).
EUS without histological examination has a high diagnostic yield in duodenal SETs. 
Xu et al. reported an efficiency of up to 93.3% in a group of 75 duodenal SETs that had a 
later histological diagnosis [4]. However, diagnostic efficiency seems to be size related, 
as Brugge et al. reported a correct diagnosis in 45% of gastric lesions less than 2 cm in 
size and proposed, naturally, EUS with fine-needle aspiration (EUS-FNA) as the gold 
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standard [10]. As literature regarding duodenal SETs is scarce, there is no consensus 
about when to perform EUS-FNA, but as previously mentioned, EUS can perform 
poorly in diagnosing small lesions, so biopsies should be performed in all lesions that 
are considered suspicious (possible malignant or with malignity potential). All lesions 
of the fourth layer (muscularis propria) should be biopsied, as most gastrointestinal 
mesenchymal tumors (GIMTs) have these characteristics. Techniques to obtain deep 
biopsies, like “jumbo” or “buttonhole” biopsies, may have better outcomes than EUS-
FNA in submucosal lesions, but carry high risk of hemorrhage [9, 11].
3. Lesions of the duodenal wall
3.1 Vascular lesions
Anechoic SETs account for a large number of different possible diagnoses. 
Doppler-color ultrasonography is the best method to differentiate between vascular 
and cystic lesions. Vascular lesions in the duodenum are most frequently varices; 
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other vascular malformations are rare. Varices are located in the third layer (sub-
mucosa) and are anechoic. Even in the absence of Doppler facilities, varices can 
be diagnosed by following their course, identifying other collateral vessels and 
perforating veins. Small varices can be compressed by the tip of the echoendoscope 
and misdiagnosed, so it is important to be careful. Therapeutic interventions like 
cyanoacrylate injection or coiling can be EUS guided.
3.2 Cystic and mixed lesions
Cystic tumors are liquid-filled cavities, hence anechogenic, that present in many 
different shapes and sizes. Many different lesions can present themselves as cystic 
or cystic-like. The most used classifications are simple cystic, polycystic or mixed 
(with liquid and solid components) [8].
3.2.1 Duplication cysts
Cysts are rounded, unilocular and clearly delineated, with a completely anechoic 
content and dorsal enhancement. The most common diagnosis is a duplication cyst, 
which forms from a maldevelopment of the gut. Duplication cysts are located in 
the third layer (submucosa) and have a characteristic duplication of all the layers of 
the gut wall. They have a low risk of malignant transformation, or they can become 
symptomatic following increasing in size, infection or rupture. EUS-FNA is rarely 
needed when the diagnosis is unclear.
3.2.2 Brunner’s gland hyperplasia
Brunner’s glands are found in the duodenum and have an alkaline secretion, 
neutralizing stomach acid. Hyperplasia of these glands is usually asymptomatic, 
but can give a polyposis-like duodenum. The cause is thought to be excessive 
stimulation from excessive gastric acids, chronic inflammation or the decrease of 
pancreatic function. They are located mainly, if not exclusively, in the duodenal 
bulb [5].
Echoendoscopic appearance can vary as isoechoic or hyperechoic, sometimes 
with cysts inside. They arise from the third layer (submucosa) and much more 
rarely from the second one (deep mucosa). The diagnosis is based on biopsy result 
(Figure 1).
3.2.3 Lymphangiomas
Lymphangiomas consist of multiple dilated lymphatic vessels situated mostly 
in the third layer (submucosa), rarely in the second layer (mucosa). They are 
thought to be benign malformations of the lymphatic system that form a mass 
in the digestive tract. Lymphangiectasias, in contrast, are dilations of exist-
ing mucosal lymphatic vessels and described endoscopically as multiple small, 
white polyp-like elevations in the duodenum. They are mainly found in the small 
intestine, have a polyp-like appearance and are soft and easily compressible with 
a normal overlying mucosa. Most are asymptomatic; rarely, the size can cause 
obstruction, abdominal pain and hemorrhage [12]. As previously mentioned, they 
are formed from dilated lymphatic vessels, but also from smooth muscle fibers 
and connective tissue. Endosonographically they most often appear as polycystic. 
Their appearance varies vastly depending on the amount of smooth muscle and 
connective tissue. When they take up a large share of the lymphangioma it appears 
inhomogeneous, rather than anechoic.
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3.2.4 Pancreatic rest
Pancreatic rest, also known as heterotopic pancreatic tissue or ectopic pancreas, 
is pancreatic tissue located, aberrantly, in the digestive tract wall, most often in the 
stomach. It is usually asymptomatic and is an incidental finding at EGD or CT scan. 
Its endoscopic characteristics are irregular overlaying mucosa and a central umbili-
cation. Rests originate from the third and fourth layer (submucosa and muscularis 
propria) and their sonographic appearance is most often mixed (solid and liquid) 
but highly variable, depending on the dominant tissue. Type 1 heterotopia consists 
of both pancreatic acini and ducts. Type 2 consists solely of pancreatic acini, and 
type 3 of pancreatic ducts. Types 1 and 2 have a hypoechoic, inhomogeneous 
sonographic appearance, poorly delineated from the surrounding tissue (second-
ary to the lobulated structure of acinous tissue). Type 3 most often appears as a 
septated cyst (multiple dilated pancreatic ducts). A characteristic appearance of a 
pancreatic rest seems to be thickening of the fourth layer behind the mass (muscu-
laris propria) [13]. Asymptomatic lesions should be followed endoscopically for size 
changes, and the rare cases of symptomatic lesions can be resected endoscopically 
by snare, band ligation or more advanced resection techniques. If the muscularis 




Lipomas are the most frequent solid, hyperechoic SETs in the duodenum. They 
are composed of mature lipocytes and originate from the third layer (the submu-
cosa). They are most common in the colon, but are also in the stomach and small 
bowel. A characteristic endoscopic appearance, with a yellowish tint and a typical 
Figure 1. 
Endoscopic (top row) and ultrasonographic (bottom row) appearance of Brunner’s gland hyperplasia.
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indent when compressing it with a biopsy forceps (“pillow” sign), does not need 
follow-up with EUS.
Echoendoscopically lipomas are hyperechoic, homogenous, arise from the third 
layer and are very well differentiated from the other layers with a clear margin. This 
typical appearance does not need histological evaluation (EUS-FNA).
Lipomas do not need treatment/resection or follow-up when they have a typical 
appearance and are asymptomatic (Figure 2).
3.3.2 GISTs
GISTs are the most common mesenchymal tumors in the GI tract, most often 
found in the stomach and much more rarely in the duodenum. They originate from 
the pacemaker cells of the digestive tract wall, the interstitial cells of Cajal. They 
are a class of SETs that present the most difficulties in diagnosis and management: 
hypoechoic SETs that originate from the muscle layers (mainly the muscularis 
propria, sometimes muscularis mucosae). They are similar in sonographic structure 
and mesenchymal origin. The molecular particularity of GISTs is a mutation in the 
gene that codes the c-Kit protein. More than 95% of them are immunohistochemi-
cal CD117 positive [15]. All GISTs have malignant potential, with the main factors 
influencing prognosis being mitotic rate, size and location (small intestinal GISTs 
seem to have a worse prognosis than gastric ones). The most common first symptom 
is GI bleeding, but a large number of GISTs are probably asymptomatic, as they are 
a common finding in postmortem examinations or in gastric resection specimens. 
GISTs in the small intestine may be more aggressive than those located in the stom-
ach, (40–50% of GISTs in the small intestine are malignant, compared with 20–25% 
of gastric GISTs) [16].
Endoscopically their appearance is similar to other SETs; a bulge in the wall of 
the digestive tract with normal overlaying mucosa. Sometimes there is a central 
ulceration or inflammation of the mucosa. They are hypoechoic, arising from a 
muscle layer. The large ones most often arise from the fourth layer (the muscularis 
propria). Leiomyomas and other mesenchymal tumors, like the schwannoma, have a 
similar appearance, but are benign. Therefore a correct diagnosis is essential before 
a therapeutic decision. Location can be the best indicator of a hypoechoic SET. In the 
duodenum they mostly turn out to be neuroendocrine tumors. More rarely they are 
GISTs or granular cell tumors, and they are almost never leiomyomas.
All GISTs have malignant potential, so even though small GISTs used to be 
followed endoscopically, the current trend is to remove all GISTs. Differentiating 
between a GIST and a leiomyoma is difficult, even with EUS-FNA/FNB sometimes, 
thus contrast enhancement is helpful in such cases.
Figure 2. 
Endoscopic (left) and ultrasonographic (right) appearance of a duodenal lipoma.
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Figure 3. 
(A) Endoscopic appearance during cap-assisted resection of a duodenal NET. (B) Same lesion after resection. 
(C) Echoendoscopic appearance of the same duodenal NET (hypoechoic, well delineated).
Figure 4. 
Endoscopic (left) and ultrasonographic (right) appearance of the papilla.
There is no specific study on contrast enhancement in case of duodenal SETs. 
A meta-analysis of gastric and esophageal SETs showed that contrast-enhanced 
endoscopic ultrasound is able to discriminate between GISTs and benign SETs with 
a pooled sensitivity of 89% and a specificity of 82%. For differentiating the malig-
nant potential of GISTs, the sensitivity was 96% and the specificity was 53% [17]. 
An uptake of the contrast with the vascular hilum present suggests a leiomyoma, 
but a heterogenous vascularity suggests GISTs while irregular vessels suggest 
malignant GISTs.
3.3.3 Neuroendocrine tumors (NETs)
NETs (also known as carcinoid tumors) are mostly asymptomatic tumors with 
endocrine cell origin. Mostly, they are discovered incidentally, but they can cause 
hemorrhage, abdominal pain or syndromes related to functional active substances 
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secreted by them. They are found along the GI tract, more often in the rectum or 
stomach, but also in the small intestine.
Their endoscopic appearance is not characteristic, usually resembling a small 
polypoid lesion with normal overlaying mucosa. Endosonographically they are 
mostly hypoechoic or isoechoic, and arise from the second layer (mucosa), but can 
extend to the third layer (submucosa).
The variety of histological types, sizes and location origins, combined with the 
risk of malignant transformation, illustrate the necessity to resect NETs. In principle, 
if the lesion is smaller than 1 cm and does not invade the muscularis propria, endo-
scopic resection is possible, otherwise surgical resection is recommended (Figure 3).
3.3.4 Major and minor papilla lesions
The upstream ducts are well recognized. Following the duodenal wall, espe-
cially the muscularis major papilla represents the opening into the duodenum 
of the common bile duct and pancreatic duct. The tumor of the papilla is very 
well visualized during EUS and the dilatation of the propria can differentiate 
small ampullary tumors that are limited to papilla from distal common bile duct 
tumors, which are situated beyond the muscularis propria layer (Figure 4).
The pancreatic accessory duct arrives in the duodenum at the level of the minor 
papilla. Sometimes EGD can confound it with an SET [4]. EUS examination can 
easily differentiate it from a tumor, as it is not part of the duodenal wall and the 
secondary duct is visible arriving at this level.
3.3.5 Adenomas
Adenomas can appear in the duodenum, as anywhere else in the GI tract, 
sporadically or part of polyposis syndromes. They are premalignant lesions that 
usually necessitate removal. Peri-papillary location makes resection techniques 
more problematic, as simple resection can cause damage to the pancreatic or biliary 
ducts. Because they are mucosal lesions (second layer), solely EGD can be used for 
management. However, EUS can be necessary in certain circumstances, such as 
evaluating the depth of invasion if a malignancy is suspected, guiding the choice 
of treatment method (lesions extending to the submucosa need more advanced 
endoscopic resection techniques or surgery) and evaluating intraductal extension in 
peri-papillary lesions (Figure 5).
3.3.6 Malignant tumors
Malignant tumors of the duodenal wall are rare. Possible malignant tumors 
identified at this level include adenocarcinomas (from adenomas), malignant mes-
enchymal tumors (malignant GISTs), malignant NETs, lymphomas and metastases 
from other cancers (very rare).
These tumors share a common endosonographic characteristic by not respect-
ing the layers of the duodenal wall (which are often lost) and often have adjacent 
lymphadenopathies.
3.4 Uncommon duodenal SETs
3.4.1 Leiomyomas
Leiomyomas are truly benign tumors arising from smooth muscle tissue, that 
is, the fourth layer and more rarely the second (muscularis mucosae). They are 
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mostly found in the esophagus, but they are described all over the GI tract. Their 
hypoechoic sonographic appearance makes them difficult to distinguish from other 
GIMTs. As such, EUS-FNA and histological examination are needed for a correct 
diagnosis. Resection is necessary only in case of symptoms.
3.4.2 Granular cell tumors
Granular cell tumors (also known as schwannomas) are benign lesions that 
arise from the peripheral nerve sheath. They are hypoechoic, homogenous, well 
delineated and arise from the second or third layer of the duodenum (submucosa 
or muscularis propria). Even though the endosonographic appearance makes them 
hard to differentiate from GISTs or leiomyomas, schwannomas are much more 
rarely encountered in the GI tract. Tissue acquisition discriminates the diagnosis in 
such situations.
3.4.3 Fibroid polyps
Fibroid polyps are rare inflammatory tumors, sometimes found in the duode-
num. They arise from the second or third layers and are usually hyperechoic and 
inhomogeneous [18].
3.4.4 Hematomas
Duodenal hematomas have been described, especially after abdominal trauma. 
However, some are spontaneous or arise from complications of endoscopic biopsies 
or other invasive maneuvers. They are usually diagnosed by CT scan or EGD. EUS is 
only needed in cases when the diagnosis is unclear, which is rare. They arise from the 
deep layers of the mucosa or submucosa (second or third layer). They have a different 
sonographic appearance depending on when they are evaluated. Initially, they have 
a heterogenous appearance in the first 24 hrs, which turns hyperechoic as more clots 
are formed and then slowly turns hypoechoic over the following weeks as it resorbs.
Figure 5. 
Top: Endoscopic view of duodenal adenoma. Bottom: Echoendoscopic appearance of the same adenomas. 
Enhanced vascularization is visible.
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3.4.5 Gangliocytic paraganglioma
Gangliocytic paragangliomas are GI mesenchymal tumors, most often found in 
the second part of the duodenum near the ampulla of Vater [19]. They are formed 
by a varying mixture of spindle cells, epithelioid cells and ganglion cells (cells 
found also in other GIMTs). They are located in the third layer (submucosa) and 
are hypoechoic and homogenous. Histology usually offers the final diagnosis, as 
hypoechoic SETs are hard to distinguish on EUS alone.
3.5 Extrinsic compressions
In a series of 169 suspected SETs in the duodenum, which were referred to 
EUS, 12 were extrinsic compressions, with seven from the gallbladder and five 
from the pancreas [4]. EUS is very efficient in these cases, as it can identify the 
layers of the duodenum wall and correctly identify the duodenal compression as 
being extrinsic, as well as determine the cause of the compression and/or invasion 
(Figures 6 and 7).
4. EUS tissue acquisition
The sampling of SELs is unnecessary in case of lipoma or duplication cyst. 
However, some duodenal SETs (GISTs, neuroendocrine tumors) have malignant 
potential, so the size of the lesion is not a limitation for tissue acquisition. The 
Figure 6. 
(A) Endoscopic view of external compression in the duodenum. (B) The echoendoscopic view shows an 
anechogenic lesion close to the transducer, a cyst. The pancreatic parenchima shows modifications consistent 
with chronic pancreatitis. (C) EUS-FNA - Paraduodenal cyst lined by inflammation and granulation tissue 
with no epitheliallining (HE-5X).
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accuracy of EUS alone compared to the final histology (ESD or surgical specimen) 
varies between 44% and 66% and tissue acquisition is important for a correct 
diagnosis [20–22].
The sampling has to be performed using bite-to-bite biopsy followed by mucosal 
resection or submucosal resection in case of the lesions belonging to the second or 
third layers [11]. In case of the lesions originating from the fourth layer, the indica-
tion is for EUS-FNA or EUS–fine-needle biopsy (EUS-FNB) [23]. The unroofing 
method for sampling of fourth-layer lesions of gastric location was compared to 
EUS-FNB, but no difference for histologic core procurement was noted [24].
EUS sampling is preferred in case of lesions situated in the third or fourth layer, 
because the risk of bleeding is usually low and seeding into the peritoneum is 
avoided compared to percutaneous biopsy.
However, the use of EUS-FNA, especially with 22-guage and 25-guage needles, gave 
a diagnostic rate of 60% in a meta-analysis of 978 patients [25]. The main limitation 
is difficulty in assessing the architecture of the lesion sampled and the mitotic index. 
No influence of SET size on the diagnostic rate of FNA was found in a retrospective 
study of 112 patients [26]. The use of a pro-core needle compared to FNA needles does 
not improve the diagnostic rate [27–30]. However, only one study included SETs from 
Figure 7. 
External invasion from a pancreatic head adenocarcinoma. (A) Endoscopic view: There are mucosal 
modifications visible (as opposed to 6A). (B) Echoendoscopic view confirms there is a pancreatic tumor. (C) 
EUS-FNA - foci of pancreatic ductal adenocarcinoma infiltrating submucosa of the duodenal wall (HE-5X).
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the duodenum [29]. The use of FNB gave better accuracy than EUS-FNA (88.03% 
vs. 77.19% [P = .030]) or EUS-FNA plus rapid on-site evaluation (ROSE) (87.25% vs. 
68.00% [P = .024]), but no difference was noted compared to EUS-FNB plus ROSE 
[31]. In a meta-analysis comprising 10 studies that compared EUS-FNB and EUS-
FNA, the diagnostic accuracy was greater in patients undergoing FNB sampling (OR, 
4.10; 95% CI, 2.48–6.79; P < .0001) with a fewer number of passes and higher rate of 
optimal core procurement (OR, 3.27; 95% CI, 2.03–5.27; P < .0001) [32]. Because the 
distal duodenum can be difficult to reach, the sampling from this location is feasible 
with thinner 25G needles, with a definitive diagnosis in 88% of patients.
5. Conclusions
EUS is essential for evaluating duodenal lesions correctly and completely. EUS 
can identify if the lesion originates from the mucosa or the deeper layers of the 
duodenal wall, or if it is extrinsic. Other diagnostic methods lack the resolution to 
distinguish between them correctly. In addition, EUS can obtain tissue for histo-
logical analysis in all cases, as EGD-guided biopsies are not deep enough for SETs. 
Choice of treatment is also decided following EUS, as benign lesions do not need 
removal, potential malignant lesions (NETs, GISTs) can be followed or resected 
and malignant lesions can be resected endoscopically if EUS does not identify 
invasion of the deeper layers. Given all this, along with the complex surroundings 
of the duodenum, its thin walls and the difficult anatomical position for surgical 
interventions, EUS is crucial in lesions of the duodenal wall.
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